Clinical Trial Update: Ketamine Infusion for Sickle Cell Pain Crisis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ketamine infusion for sickle cell pain crisis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Sickle Cell Disease with Crisis

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Duke University | Conditions: Anemia; Sickle-Cell, With Crisis, Acute Pain | Phase 4 | Status: WITHDRAWN